Public-registry site landscape for NCT03510897, a Cardiac Surgery study sponsored by Quark Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03510897 (registry record) |
| Sponsor | Quark Pharmaceuticals |
| Condition(s) | Cardiac Surgery |
| Phase | PHASE3 |
| Listed sites | 104 |
| Site countries | United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, New Zealand, Spain, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT03510897 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →